Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Otsuka Pharmaceutical Co., Ltd.
Pharmaceutical Preparation ManufacturingJapan
Last verified 15 days agootsuka.co.jp
Otsuka Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in Japan. Founded in 1964, the company has established a strong presence in various global markets, focusing on innovative healthcare solutions. Otsuka is renowned for its unique approach to drug development, particularly in areas such as mental health, nephrology, and oncology.
The company’s core products include prescription medications and nutraceuticals, distinguished by their commitment to research and development. Otsuka's notable achievements include pioneering treatments that address unmet medical needs, solidifying its position as a leader in the pharmaceutical sector. With a dedication to improving patient outcomes, Otsuka continues to expand its influence in the healthcare landscape, driven by a mission to create new value in medicine.
38
DitchCarbon score
-4 vs industry average
Otsuka Pharmaceutical Co., Ltd.’s score of 38 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Otsuka Pharmaceutical Co., Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
High
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Otsuka Pharmaceutical Co., Ltd.'s reported carbon emissions
Otsuka Pharmaceutical Co., Ltd., a Japanese pharmaceutical preparation manufacturer, reported its Scope 1 emissions at 2,600,000 kg CO2e and Scope 2 emissions at 1,005,000 kg CO2e for 2024. This marks a decrease from 2023, when Scope 1 emissions were 2,600,000 kg CO2e and Scope 2 emissions were 1,226,000 kg CO2e.
The company has set Science Based Targets initiative (SBTi) approved near-term targets. Otsuka Pharmaceutical Co., Ltd. commits to reduce absolute Scope 1 and 2 GHG emissions by 30% by 2030, using a 2017 base year. Additionally, the company aims to reduce absolute Scope 3 GHG emissions by 20% by 2030, also from a 2017 base year. These targets are consistent with reductions required to keep global warming to 2°C. These reduction targets were set by Otsuka Pharmaceutical Co., Ltd. itself.
Assessing Otsuka Pharmaceutical Co., Ltd. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Otsuka Pharmaceutical Co., Ltd. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Otsuka Pharmaceutical Co., Ltd.’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
2030 targetSee details
Active
Carbon Disclosure Project
Inherited from Otsuka Holdings Co., Ltd.Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
Inherited from Otsuka Holdings Co., Ltd.See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Otsuka Pharmaceutical Co., Ltd.15 days ago
38
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Otsuka Pharmaceutical Co., Ltd.’s sustainability data and climate commitments
In 2024, Otsuka Pharmaceutical Co., Ltd. reported total Scope 1 and Scope 2 greenhouse gas emissions of approximately 3.6 million kg CO2e. This figure comprises roughly 2.6 million kg CO2e from Scope 1 and around 1.0 million kg CO2e from Scope 2. These emissions are reported at the global level for the company's operations. The company's reporting indicates a decrease in Scope 2 emissions compared to the previous year, reflecting ongoing efforts in emissions management within the pharmaceutical preparation manufacturing sector.
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more